120
Views
27
CrossRef citations to date
0
Altmetric
Review

The HLA-A*31:01 allele: influence on carbamazepine treatment

&
Pages 29-38 | Published online: 31 Jan 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ramón Cacabelos, Natalia Cacabelos & Juan C. Carril. (2019) The role of pharmacogenomics in adverse drug reactions. Expert Review of Clinical Pharmacology 12:5, pages 407-442.
Read now
Amy Sharma, Yoshiro Saito, Shuen-Iu Hung, Dean Naisbitt, Jack Uetrecht & Jeanine Bussiere. (2019) The skin as a metabolic and immune-competent organ: Implications for drug-induced skin rash. Journal of Immunotoxicology 16:1, pages 1-12.
Read now
Ingrid Fricke-Galindo, Adrián LLerena, Helgi Jung-Cook & Marisol López-López. (2018) Carbamazepine adverse drug reactions. Expert Review of Clinical Pharmacology 11:7, pages 705-718.
Read now
Laurent M. Willems, Johann Philipp Zöllner, Esther Paule, Susanne Schubert-Bast, Felix Rosenow & Adam Strzelczyk. (2018) Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence. Expert Review of Clinical Pharmacology 11:3, pages 309-324.
Read now

Articles from other publishers (23)

Mandana Hasanzad, Negar Sarhangi, Hamid Reza Aghaei Meybodi & Shekoufeh Nikfar. 2023. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Lisanne E. N. Manson, Patricia C. Y. Chan, Stefan Böhringer & Henk-Jan Guchelaar. (2022) Genotyping for HLA risk alleles versus patch tests to diagnose anti-seizure medication induced cutaneous adverse drug reactions. Frontiers in Pharmacology 13.
Crossref
Pei Xi, Hao Wang, Zihua Zhong, Shihui Liu, Jiaxuan Tang, Chunli Guo & Penggao Dai. (2022) rs144012689 is a highly specific representative marker of HLA-B*15:02 in the Chinese population . Pharmacogenomics 23:15, pages 835-845.
Crossref
Zahra Abdulathim Alhaddad, Hissah Abdullatif AlMousa & Nancy S. Younis. (2022) Pharmacists’ Knowledge, and Insights in Implementing Pharmacogenomics in Saudi Arabia. International Journal of Environmental Research and Public Health 19:16, pages 10073.
Crossref
Vanessa Câmara Fernandes, Marco Antônio M. Pretti, Luiza Tamie Tsuneto, Maria Luiza Petzl-Erler & Guilherme Suarez-Kurtz. (2022) Single Nucleotide Variants as Proxies for HLA-A*31:01 in Native American Populations. Frontiers in Pharmacology 13.
Crossref
Kim Morley. (2021) Enhancing patients’ experiences of living with epilepsy. Nursing Standard 37:1, pages 29-34.
Crossref
Sofi Imtiyaz Ali, Muzafar Ahmad Rather, Wajid Mohammad Sheikh, Showkat Ul Nabi, Alveena Ganai, Mehvish Altaf, Subhradal Nath, Sheikh Bilal Ahmad, Imtiyaz Ahmad Wani & Showkeen Muzamil Bashir. 2022. A Molecular Approach to Immunogenetics. A Molecular Approach to Immunogenetics 347 384 .
Y.W. Francis Lam. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 277 301 .
Nilupaer Shafeng, Deng-feng Han, Yun-fang Ma, Rena Abudusalamu & Binuer Ayitimuhan. (2021) Association between the HLA-B*1502 gene and mild maculopapular exanthema induced by antiepileptic drugs in Northwest China. BMC Neurology 21:1.
Crossref
Marina Villanueva-Paz, Hao Niu, Antonio Segovia-Zafra, Inmaculada Medina-Caliz, Judith Sanabria-Cabrera, M. Isabel Lucena, Raúl J. Andrade & Ismael Alvarez-Alvarez. (2021) Critical Review of Gaps in the Diagnosis and Management of Drug-Induced Liver Injury Associated with Severe Cutaneous Adverse Reactions. Journal of Clinical Medicine 10:22, pages 5317.
Crossref
Gia-Gia Toni Hò, Wiebke Hiemisch, Andreas Pich, Michelle Matern, Lareen Sophi Gräser, Rainer Blasczyk, Christina Bade-Doeding & Gwendolin Sabrina Simper. 2021. New Insights into the Future of Pharmacoepidemiology and Drug Safety. New Insights into the Future of Pharmacoepidemiology and Drug Safety.
Iman Imtiyaz Ahmed Juvale & Ahmad Tarmizi Che Has. (2020) Possible interplay between the theories of pharmacoresistant epilepsy. European Journal of Neuroscience 53:6, pages 1998-2026.
Crossref
Abderrahim Oussalah, Vincent Yip, Cristobalina Mayorga, Miguel Blanca, Annick Barbaud, Alla Nakonechna, Josefina Cernadas, Maia Gotua, Knut Brockow, Jean‐Christoph Caubet, Andreas Bircher, Marina Atanaskovic‐Markovic, Pascal Demoly, Luciana Kase‐Tanno, Ingrid Terreehorst, José Julio Laguna, Antonino Romano, Jean‐Louis Guéant & Munir Pirmohamed. (2020) Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA‐compliant systematic review—An EAACI position paper. Allergy 75:5, pages 1069-1098.
Crossref
Chad A. Bousman, Lisa C. Brown, Ajeet B. Singh, Harris A. Eyre & Daniel J. Müller. 2020. Personalized Psychiatry. Personalized Psychiatry 437 448 .
Judith Sanabria-Cabrera, Inmaculada Medina-Cáliz, Simona Stankevičiūtė, Antonio Rodríguez-Nicolás, Marina Almarza-Torres, M. Isabel Lucena & Raúl J. Andrade. (2019) Drug-Induced liver Injury Associated with Severe Cutaneous Hypersensitivity Reactions: A Complex Entity in Need of a Multidisciplinary Approach. Current Pharmaceutical Design 25:36, pages 3855-3871.
Crossref
Gwendolin S. Simper, Lareen S. Gräser, Alexander A. Celik, Joachim Kuhn, Heike Kunze-Schumacher, Gia-Gia T. Hò, Rainer Blasczyk, Andreas Pich & Christina Bade-Doeding. (2019) The Mechanistic Differences in HLA-Associated Carbamazepine Hypersensitivity. Pharmaceutics 11:10, pages 536.
Crossref
Natalia Pérez-Sánchez, Raquel Jurado-Escobar, Inmaculada Doña, Víctor Soriano-Gomis, Carmen Moreno-Aguilar, Joan Bartra, María Isidoro-García, María José Torres & José Antonio Cornejo-García. (2019) Pharmacogenomics as a Tool for Management of Drug Hypersensitivity Reactions. Current Treatment Options in Allergy 6:1, pages 1-17.
Crossref
Ruwen Böhm, Ehrhardt Proksch, Thomas Schwarz & Ingolf Cascorbi. (2018) Drug Hypersensitivity: Diagnosis, Genetics, and Prevention. Deutsches Ärzteblatt international.
Crossref
Tingting Zhang, Ying Xiao, Yanxia Wang, Yanwei Li, Lirong Zhang, Chao Chen & Huijuan Wang. (2018) Single-tube multiplex real-time PCR assay for rapid and reliable detection of HLA-A*31:01 allele . Pharmacogenomics 19:10, pages 837-846.
Crossref
Kalliopi Gerogianni, Aspasia Tsezou & Konstantinos Dimas. (2018) Drug-Induced Skin Adverse Reactions: The Role of Pharmacogenomics in Their Prevention. Molecular Diagnosis & Therapy 22:3, pages 297-314.
Crossref
A. J. Redwood, R. K. Pavlos, K. D. White & E. J. Phillips. (2018) HLAs: Key regulators of T-cell-mediated drug hypersensitivity. HLA 91:1, pages 3-16.
Crossref
Katie D. White, Riichiro Abe, Michael Ardern-Jones, Thomas Beachkofsky, Charles Bouchard, Bruce Carleton, James Chodosh, Ricardo Cibotti, Robert Davis, Joshua C. Denny, Roni P. Dodiuk-Gad, Elizabeth N. Ergen, Jennifer L. Goldman, James H. HolmesIVIV, Shuen-Iu Hung, Mario E. Lacouture, Rannakoe J. Lehloenya, Simon Mallal, Teri A. Manolio, Robert G. Micheletti, Caroline M. Mitchell, Maja Mockenhaupt, David A. Ostrov, Rebecca Pavlos, Munir Pirmohamed, Elena Pope, Alec Redwood, Misha Rosenbach, Michael D. Rosenblum, Jean-Claude Roujeau, Arturo P. Saavedra, Hajirah N. Saeed, Jeffery P. Struewing, Hirohiko Sueki, Chonlaphat Sukasem, Cynthia Sung, Jason A. Trubiano, Jessica Weintraub, Lisa M. Wheatley, Kristina B. Williams, Brandon Worley, Wen-Hung Chung, Neil H. Shear & Elizabeth J. Phillips. (2018) SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. The Journal of Allergy and Clinical Immunology: In Practice 6:1, pages 38-69.
Crossref
Patricia T. Illing, Anthony W. Purcell & James McCluskey. (2017) The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions. Immunogenetics 69:8-9, pages 617-630.
Crossref